This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (96)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Genetics  • Genetic Counseling/ Testing/ Therapy  • Genetics, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Karen K. Steinberg, PhD; Mary E. Cogswell, DrPH; Joy C. Chang, PhD; Samuel P. Caudill, PhD; Geraldine M. McQuillan, PhD; Barbara A. Bowman, PhD; Laurence M. Grummer-Strawn, DrPH; Eric J. Sampson, PhD; Muin J. Khoury, MD,PhD; Margaret L. Gallagher, PhD

JAMA. 2001;285:2216-2222.

Context  Population-based estimates of the prevalence of disease-associated mutations, such as hemochromatosis (HFE) gene mutations, are needed to determine the usefulness of genetic screening.

Objective  To estimate the prevalence of the HFE mutations C282Y and H63D in the US population.

Design  Cross-sectional population-based study of samples in the DNA bank from phase 2 of the Third National Health and Nutrition Examination Survey conducted from 1992 to 1994.

Setting and Participants  Genotyped samples of cells from a total of 5171 participants, cross-classified by sex, age, and race/ethnicity in the analysis.

Main Outcome Measures  Estimates of the prevalence of C282Y and H63D mutations.

Results  The prevalence of C282Y homozygosity is estimated to be 0.26% (95% confidence interval [CI], 0.12%-0.49%); 1.89% (95% CI, 1.48%-2.43%) for H63D homozygosity; and 1.97% (95% CI, 1.54%-2.49%) for compound heterozygosity. The prevalence estimates for C282Y heterozygosity (C282Y/wild type) are 9.54% among non-Hispanic whites, 2.33% among non-Hispanic blacks, and 2.75% among Mexican-Americans. The prevalence estimates of the C282Y mutation in the US population are 5.4% (95% CI, 4.7%-6.2%) and 13.5% (95% CI, 12.5%-14.8%) for the H63D mutation.

Conclusions  Estimates of prevalence of HFE mutations are within the expected range for non-Hispanic whites and blacks but the estimated prevalence of the C282Y mutation among Mexican-Americans is less than expected. Mutation data now need to be linked to clinically relevant indices, such as transferrin saturation level.

Author Affiliations: Division of Laboratory Sciences (Drs Steinberg, Chang, Caudill, Sampson, and Gallagher), Office of Genetics and Disease Prevention (Dr Khoury), National Center for Environmental Health, and Divisions of Nutrition and Physical Activity (Drs Cogswell and Grummer-Strawn) and Diabetes Translation (Dr Bowman), National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Chamblee, Ga; and Division of Health Examination Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, Rockville, Md (Dr McQuillan).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

May 2, 2001
JAMA. 2001;285(17):2263-2264.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Potentiation of Doxorubicin Cardiotoxicity by Iron Loading in a Rodent Model
Panjrath et al.
J Am Coll Cardiol 2007;49:2457-2464.
ABSTRACT | FULL TEXT  

The Association Between H63D Mutations in HFE and Amyotrophic Lateral Sclerosis in a Dutch Population
Sutedja et al.
Arch Neurol 2007;64:63-67.
ABSTRACT | FULL TEXT  

HFE Genetic Variability, Body Iron Stores, and the Risk of Type 2 Diabetes in U.S. Women
Qi et al.
Diabetes 2005;54:3567-3572.
ABSTRACT | FULL TEXT  

Iron supplement use and iron status among US adults: results from the third National Health and Nutrition Examination Survey
Blanck et al.
Am. J. Clin. Nutr. 2005;82:1024-1031.
ABSTRACT | FULL TEXT  

Hemochromatosis Gene Mutations, Body Iron Stores, Dietary Iron, and Risk of Colorectal Adenoma in Women
Chan et al.
JNCI J Natl Cancer Inst 2005;97:917-926.
ABSTRACT | FULL TEXT  

Hereditary hemochromatosis is reflected in the iron isotope composition of blood
Krayenbuehl et al.
Blood 2005;105:3812-3816.
ABSTRACT | FULL TEXT  

Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population
Adams et al.
NEJM 2005;352:1769-1778.
ABSTRACT | FULL TEXT  

Hemochromatosis Gene Mutations and Distal Adenomatous Colorectal Polyps
McGlynn et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:158-163.
ABSTRACT | FULL TEXT  

Detecting the C282Y and H63D Mutations of the HFE Gene by Holliday Junction-Based Allele-Specific Genotyping Methods
Yang et al.
Clin. Chem. 2005;51:210-213.
FULL TEXT  

Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis
Hunt and Zeng
Am. J. Clin. Nutr. 2004;80:924-931.
ABSTRACT | FULL TEXT  

The emergence of epidemiology in the genomics age
Khoury et al.
Int J Epidemiol 2004;33:936-944.
FULL TEXT  

HFE mutations are not strongly associated with sporadic ALS
Yen et al.
Neurology 2004;62:1611-1612.
ABSTRACT | FULL TEXT  

Increased Prevalence of the HFE C282Y Hemochromatosis Allele in Women with Breast Cancer
Kallianpur et al.
Cancer Epidemiol. Biomarkers Prev. 2004;13:205-212.
ABSTRACT | FULL TEXT  

Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis
Tomatsu et al.
Proc. Natl. Acad. Sci. USA 2003;100:15788-15793.
ABSTRACT | FULL TEXT  

Hereditary Hemochromatosis and Its Elusive Natural History
McDonnell and Parrish
Arch Intern Med 2003;163:2421-2423.
FULL TEXT  

HFE Gene Mutations in Chile
Wohllk et al.
ANN INTERN MED 2003;139:708-709.
FULL TEXT  

Bioavailability of iron, zinc, and other trace minerals from vegetarian diets
Hunt
Am. J. Clin. Nutr. 2003;78:633S-639.
ABSTRACT | FULL TEXT  

The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis
Beutler
Blood 2003;101:3347-3350.
FULL TEXT  

Rebuttal to Ajioka and Kushner
Beutler
Blood 2003;101:3354-3357.
FULL TEXT  

Association Between Hemochromatosis (HFE) Gene Mutation Carrier Status and the Risk of Colon Cancer
Shaheen et al.
JNCI J Natl Cancer Inst 2003;95:154-159.
ABSTRACT | FULL TEXT  

Population Screening in the Age of Genomic Medicine
Khoury et al.
NEJM 2003;348:50-58.
FULL TEXT  

Iron stores and cardiovascular disease risk factors in women of reproductive age in the United States
Ramakrishnan et al.
Am. J. Clin. Nutr. 2002;76:1256-1260.
ABSTRACT | FULL TEXT  

Do body iron stores increase the risk of developing coronary heart disease?
Sempos
Am. J. Clin. Nutr. 2002;76:501-503.
FULL TEXT  

Prevalence of HFE gene C282Y and H63D mutations in a French-Canadian population of neonates and in referred patients
Girouard et al.
Hum Mol Genet 2002;11:185-189.
ABSTRACT | FULL TEXT  

Genetic Testing and Medical Decision Making
Reyna et al.
Arch Intern Med 2001;161:2406-2408.
FULL TEXT  

Association of Mutations in the Hemochromatosis Gene With Shorter Life Expectancy
Bathum et al.
Arch Intern Med 2001;161:2441-2444.
ABSTRACT | FULL TEXT